BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15011208)

  • 1. Anterolateral and lateral skull-base approaches for treatment of neoplastic diseases.
    Carrillo JF; Rivas Leon B; Celis MA; Ponce-de-Leon S; Ochoa-Carrillo FJ
    Am J Otolaryngol; 2004; 25(1):58-67. PubMed ID: 15011208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Craniofacial resection for cranial base malignancies involving the infratemporal fossa.
    Bilsky MH; Bentz B; Vitaz T; Shah J; Kraus D
    Neurosurgery; 2005 Oct; 57(4 Suppl):339-47; discussion 339-47. PubMed ID: 16234683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined subcranial approaches for excision of complex anterior skull base tumors.
    Fliss DM; Abergel A; Cavel O; Margalit N; Gil Z
    Arch Otolaryngol Head Neck Surg; 2007 Sep; 133(9):888-96. PubMed ID: 17875855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant tumors of the anterolateral skull base.
    Hentschel SJ; Vora Y; Suki D; Hanna EY; DeMonte F
    Neurosurgery; 2010 Jan; 66(1):102-12; discussion 112. PubMed ID: 20023541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical management of carcinomas of the infratemporal fossa and skull base: patterns of failure and predictors of long-term outcomes.
    Amit M; Bell D; Hunt PJ; Hanna E; Su SY; Kupferman M; Aashiq M; Takahashi H; Gidley PW; Nader ME; DeMonte F; Raza SM
    J Neurosurg; 2020 Jun; 134(5):1392-1398. PubMed ID: 32534492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ameloblastic fibrosarcoma involving the anterior and middle skull base with intradural extension.
    Guthikonda B; Hanna EY; Skoracki RJ; Prabhu SS
    J Craniofac Surg; 2009 Nov; 20(6):2087-90. PubMed ID: 19884826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transtemporal and transinfratemporal combined approaches in lateral skull base tumor surgery].
    Wang Z
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1999 Apr; 34(2):95-7. PubMed ID: 12764857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subtemporal-preauricular approach in the management of infratemporal and nasopharyngeal tumours.
    Llorente JL; Nazar G; Cabanillas R; Fernández de León R; Suárez C
    J Otolaryngol; 2006 Jun; 35(3):173-9. PubMed ID: 16929993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical strategy for tumors located in or extending from the intracranial space to the infratemporal fossa-Advantages of the transcranial approach (zygomatic infratemporal fossa approach) and the indications for a combined transcranial and transcervical approach-.
    Yoshida K; Kawase T; Tomita T; Ogawa K; Kawana H; Yago K; Asanami S
    Neurol Med Chir (Tokyo); 2009 Dec; 49(12):580-6. PubMed ID: 20035132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoplastic Anterior Transoral Approach for Tumors of the Middle Cranial Fossa.
    Nicolás S; Ejusmar R; Lozano A; Lobo C
    J Craniofac Surg; 2019; 30(8):2313-2314. PubMed ID: 31283643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of malignant neoplasms of the lateral cranial base with the combined frontotemporal-anterolateral approach: five-year follow-up.
    Bigelow DC; Smith PG; Leonetti JP; Backer RL; Grubb RL; Kotapka MJ
    Otolaryngol Head Neck Surg; 1999 Jan; 120(1):17-24. PubMed ID: 9914544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumors of the skull base in children and adolescents.
    Hanbali F; Tabrizi P; Lang FF; DeMonte F
    J Neurosurg; 2004 Feb; 100(2 Suppl Pediatrics):169-78. PubMed ID: 14758945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in pterygopalatine and infratemporal fossa malignant tumours: A single institution experience.
    He Y; Yang H; Sun J; Zhang C; Zhu H; Liu Z
    J Craniomaxillofac Surg; 2015 May; 43(4):537-44. PubMed ID: 25819099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Craniofacial resection for malignant melanoma of the skull base: report of an international collaborative study.
    Ganly I; Patel SG; Singh B; Kraus DH; Bridger PG; Cantu G; Cheesman A; De Sa G; Donald P; Fliss DM; Gullane P; Janecka I; Kamata SE; Kowalski LP; Levine PA; Medina dos Santos LR; Pradhan S; Schramm V; Snyderman C; Wei WI; Shah JP
    Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):73-8. PubMed ID: 16415433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of endoscopic transnasal surgery for skull base chondrosarcoma: a retrospective analysis of 19 cases at a single institution.
    Hasegawa H; Shin M; Kondo K; Hanakita S; Mukasa A; Kin T; Saito N
    J Neurosurg; 2018 May; 128(5):1438-1447. PubMed ID: 28686110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of lesions involving both the infratemporal fossa and middle skull base.
    Bao S; Ni S; Zhang J; Li L; Mo D; Guo C; Zhang J; Yu G; You Y
    Surg Neurol; 2006; 66 Suppl 1():S10-7; discussion S17. PubMed ID: 16904988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skull base chondrosarcomas: surgical treatment and results.
    Sbaihat A; Bacciu A; Pasanisi E; Sanna M
    Ann Otol Rhinol Laryngol; 2013 Dec; 122(12):763-70. PubMed ID: 24592579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of 59 consecutive patients with lesions of the anterior cranial base operated on using the subcranial approach.
    Kinnunen I; Aitasalo K
    J Craniomaxillofac Surg; 2006 Oct; 34(7):405-11. PubMed ID: 16965917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skull base approaches in the pediatric population.
    Gil Z; Constantini S; Spektor S; Abergel A; Khafif A; Beni-Adani L; Leonor TL; DeRowe A; Fliss DM
    Head Neck; 2005 Aug; 27(8):682-9. PubMed ID: 15957193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of resection of infratemporal fossa tumors.
    Givi B; Liu J; Bilsky M; Mehrara B; Disa J; Pusic A; Cordeiro P; Shah JP; Kraus DH
    Head Neck; 2013 Nov; 35(11):1567-72. PubMed ID: 23322409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.